Alnylam Pharmaceuticals Inc - Company Profile
Powered by 
All the sales intelligence you need on Alnylam Pharmaceuticals Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Alnylam Pharmaceuticals Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Alnylam Pharmaceuticals Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View up-to-date information on Alnylam Pharmaceuticals Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230392156A1 | Application | G protein-coupled receptor 75 (GPR75) irna compositions and methods of use thereof | C12N15/1138; C12N2310/14; C12N2310/315; C12N2310/3515; A61P3/04 | December 07, 2023 |
| US20230392155A1 | Application | Methods and compositions for treating primary hyperoxaluria | C12N15/1137; C12N2310/14; C12N2310/351; C12N2320/35; C12Y101/03015; A61P3/00 | December 07, 2023 |
| US20230390321A1 | Application | Complement component c5 irna compositions and methods of use thereof | C12N15/113; C12N2310/14; C12N2310/322; C12N2310/3515; A61K31/7105; A61K31/713; A61K48/0066; A61K9/0019; C07K14/472; C07K16/18 | December 07, 2023 |
| US20230392152A1 | Application | Huntingtin (HTT) irna agent compositions and methods of use thereof | C12N15/113; C12N2310/14; C12N2310/315; C12N2310/321; C12N2310/322 | December 07, 2023 |
| EP4284390A1 | Application | Irna-zusammensetzungen und verfahren zur silencing von amyloidvorläuferprotein (APP) | C12N15/113; C12N2310/14; C12N2310/315; C12N2310/343; C12N2310/3515; C12N2320/11; A61K31/713; A61P25/28 | December 06, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer